Abstract
Observational studies in general surgery patients in noncritical settings have suggested that hyperglycemia is associated with perioperative complications and mortality. Secondary to changes in oral intake during the perioperative period, oral antidiabetic medications traditionally are withheld and replaced with sliding-scale insulin (SSI) therapy. U.S. researchers conducted a three-center trial to compare basal-bolus insulin therapy to SSI in general surgery patients with type 2 diabetes. Oral antidiabetic medications were discontinued on admission. Patients randomized to basal-bolus therapy received total daily …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
